KENDALYN FELTS: Open Payments
NPI 1902476567 · SUFFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,428 in 200 payments from 15 companies in 2025. Trend: 2023 $59 · 2024 $522 · 2025 $4,428
Food & beverage: $4,167Education: $261
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $841 |
| Galderma Laboratories, L.P. | 41 | $606 |
| Janssen Biotech, Inc. | 23 | $528 |
| GENZYME CORPORATION | 12 | $490 |
| Regeneron Healthcare Solutions, Inc. | 13 | $490 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $360 |
| E.R. Squibb & Sons, L.L.C. | 21 | $301 |
| UCB, Inc. | 13 | $276 |
| Arcutis Biotherapeutics, Inc. | 6 | $169 |
| SANOFI-AVENTIS U.S. LLC | 1 | $92 |
Products named: DUPIXENT, TREMFYA, RINVOQ, SKYRIZI, Sotyktu, Bimzelx, NEMLUVIO, Winlevi.
Industry payments across VA — which companies pay providers there.
